It was pointed out recently that 10 to 20% of patients who had received immunotherapy treated with anti-CTLA-4 antibody showed increases of their tumor sizes at 3 months after starting the administration but no more tumor progression occurred without any additional intervention9. Here, CTLA4 is linked to neoplasm.